Silva, Joyce Teixeira da; Evangelista, Bianca G.; Venega, Rafael Augusto Galdino 
; Seminowicz, David A.; Chacur, Marucia
Source: Behavioural Pharmacology. Unidade: ICB
Subjects: ANATOMIA, CATALEPSIA, ANTIPSICÓTICOS, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Joyce Teixeira da et al. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behavioural Pharmacology, v. 30, n. 1, p. 79-88, 2019Tradução . . Disponível em: https://doi.org/10.1097/FBP.0000000000000422. Acesso em: 14 nov. 2024.APA
Silva, J. T. da, Evangelista, B. G., Venega, R. A. G., Seminowicz, D. A., & Chacur, M. (2019). Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats. Behavioural Pharmacology, 30( 1), 79-88. doi:10.1097/FBP.0000000000000422NLM
Silva JT da, Evangelista BG, Venega RAG, Seminowicz DA, Chacur M. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats [Internet]. Behavioural Pharmacology. 2019 ;30( 1): 79-88.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1097/FBP.0000000000000422Vancouver
Silva JT da, Evangelista BG, Venega RAG, Seminowicz DA, Chacur M. Anti-NGF treatment can reduce chronic neuropathic pain by changing peripheral mediators and brain activity in rats [Internet]. Behavioural Pharmacology. 2019 ;30( 1): 79-88.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1097/FBP.0000000000000422
